Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Further, as more companies enter the race starting in 2027, additional price declines are expected
Lilly CEO David Ricks framed the approval in terms of access: " Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment, " Ricks said in the company's April 1 press release
Independently batch tested for identity and purity
A vendor who cannot explain how their retatrutide was synthesized, purified, and tested probably does not know, which means quality control is not a priority
US$ 29.29
US$ 25.07
US$ 28.70
US$ 27.86
